Severe tirofiban-induced thrombocytopenia following percutaneous coronary intervention
Abstract Tirofiban is an intravenous glycoprotein IIb/IIIa inhibitor (GPI) that can be used as a bailout strategy in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with…